Publication Name	World Journal of Gastroenterology
Manuscript ID	20219
Country	United States

Received	2015-05-30 12:00
Peer-Review Started	2015-06-03 18:39
To Make the First Decision	2015-06-23 15:05
Return for Revision	2015-06-26 17:53
Revised	2015-07-15 22:50
Second Decision	2015-09-28 16:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-30 10:30
Articles in Press	2015-09-30 10:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-12 15:34
Publish the Manuscript Online	2015-10-23 15:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Molecular detection of pancreatic neoplasia: Current status and future promise
Manuscript Source	Invited Manuscript
All Author List	Shounak Majumder, Suresh T Chari and David A Ahlquist
Funding Agency and Grant Number
Corresponding Author	Dr. Shounak Majumder, MD, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. majumder.shounak@mayo.edu
Key Words	Early detection of cancer; Sensitivity and specificity; Pancreatic cancer; Pancreatic juice; Stool; Pancreatic cyst fluid; Biomarkers; Methylation
Core Tip	Pancreatic cancer is a leading cause of cancer mortality worldwide. Early detection at a resectable stage is associated with the best long-term prognosis. There are ongoing efforts globally to discover, validate and optimize molecular markers for early diagnosis. The challenge is to develop highly sensitive markers not only for earliest stage cancer but also to accurately detect premalignant lesions with high grade dysplasia that would maximally benefit from resection. In this review, we summarize some of the most promising biomarkers for molecular detection of pancreatic cancer and discuss evolving molecular approaches.
Publish Date	2015-10-23 15:45
Citation	Majumder S, Chari ST, Ahlquist DA. Molecular detection of pancreatic neoplasia: Current status and future promise. World J Gastroenterol 2015; 21(40): 11387-11395
URL	http://www.wjgnet.com/1007-9327/full/v21/i40/11387.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i40.11387

Full Article (PDF)	WJG-21-11387.pdf
Full Article (Word)	WJG-21-11387.doc
Manuscript File	20219-Review.docx
Answering Reviewers	20219-Answering reviewers.pdf
Audio Core Tip	20219-Audio core tip.wav
Copyright License Agreement	20219-Copyright assignment.pdf
Peer-review Report	20219-Peer-review(s).pdf
Scientific Misconduct Check	20219-Scientific misconduct check.pdf
Scientific Editor Work List	20219-Scientific editor work list.pdf